Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,147 | 335 | 96.7% |
| Education | $174.98 | 2 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $534.92 | 56 | $0 (2024) |
| Forte Bio-Pharma LLC | $469.28 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $439.73 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $311.36 | 18 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $308.69 | 19 | $0 (2022) |
| Lilly USA, LLC | $297.34 | 21 | $0 (2024) |
| Astellas Pharma US Inc | $275.60 | 9 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $265.70 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $263.52 | 19 | $0 (2022) |
| Novo Nordisk Inc | $228.20 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $471.39 | 19 | Astellas Pharma US Inc ($174.98) |
| 2023 | $172.83 | 10 | Forte Bio-Pharma LLC ($31.46) |
| 2022 | $996.84 | 62 | ABBVIE INC. ($284.76) |
| 2021 | $1,507 | 103 | AbbVie Inc. ($216.04) |
| 2020 | $1,602 | 104 | Forte Bio-Pharma LLC ($156.70) |
| 2019 | $270.73 | 18 | PFIZER INC. ($61.59) |
| 2018 | $217.52 | 15 | AstraZeneca Pharmaceuticals LP ($52.40) |
| 2017 | $83.71 | 6 | AstraZeneca Pharmaceuticals LP ($31.19) |
All Payment Transactions
337 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $17.43 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Gastroenterology | ||||||
| 07/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Psychology/Psychiatric | ||||||
| 07/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: PSYCHIATRY | ||||||
| 06/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Cardio-renal | ||||||
| 06/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: PSYCHIATRY | ||||||
| 05/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: PSYCHIATRY | ||||||
| 05/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Respiratory | ||||||
| 04/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Inflammation | ||||||
| 01/16/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.99 | General |
| 01/16/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $79.99 | General |
| 01/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 08/28/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Diabetes | ||||||
| 04/10/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/23/2023 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: PAIN | ||||||
| 03/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/14/2023 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 305 | 478 | $57,502 | $18,561 |
| 2022 | 15 | 663 | 1,051 | $86,719 | $28,489 |
| 2021 | 4 | 289 | 839 | $125,485 | $47,393 |
| 2020 | 8 | 519 | 1,306 | $178,998 | $54,235 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 139 | $30,188 | $9,477 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 142 | $20,317 | $7,268 | 35.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 37 | 37 | $1,739 | $485.44 | 27.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 38 | 39 | $1,794 | $395.65 | 22.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 37 | 42 | $261.00 | $249.16 | 95.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 14 | 14 | $1,134 | $230.44 | 20.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 28 | $744.00 | $180.67 | 24.3% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 22 | 23 | $667.00 | $140.95 | 21.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 14 | $658.00 | $133.28 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 152 | $34,656 | $11,950 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 157 | $22,922 | $9,261 | 40.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 89 | 161 | $7,567 | $2,095 | 27.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 91 | 165 | $7,590 | $1,702 | 22.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 34 | 50 | $4,050 | $829.97 | 20.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 35 | 68 | $3,196 | $634.80 | 19.9% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 55 | 69 | $2,001 | $436.18 | 21.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $384.00 | $331.00 | 86.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 73 | 93 | $558.00 | $274.67 | 49.2% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 14 | 18 | $540.00 | $263.21 | 48.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 29 | 33 | $1,188 | $253.93 | 21.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 25 | $675.00 | $179.33 | 26.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 17 | 19 | $779.00 | $158.48 | 20.3% |
| 83735 | Magnesium level | Office | 2022 | 12 | 14 | $448.00 | $86.37 | 19.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 15 | $165.00 | $33.39 | 20.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 136 | 527 | $74,307 | $29,004 | 39.0% |
About Dr. David Rodriguez, M.D
Dr. David Rodriguez, M.D is a Family Medicine healthcare provider based in Lake City, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952399222.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Rodriguez, M.D has received a total of $5,322 in payments from pharmaceutical and medical device companies, with $471.39 received in 2024. These payments were reported across 337 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,147).
As a Medicare-enrolled provider, Rodriguez has provided services to 1,776 Medicare beneficiaries, totaling 3,674 services with total Medicare billing of $148,677. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lake City, SC
- Active Since 10/11/2005
- Last Updated 04/13/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952399222
Products in Payments
- VRAYLAR (Drug) $288.11
- REXULTI (Drug) $265.70
- FARXIGA (Drug) $254.82
- JARDIANCE (Drug) $245.59
- SOLIQUA 100/33 (Biological) $240.09
- TRINTELLIX (Drug) $222.54
- NALOCET (Drug) $184.73
- UBRELVY (Drug) $161.27
- Nalocet (Drug) $156.70
- EMGALITY (Drug) $138.01
- PROLATE (Drug) $127.85
- CHANTIX (Drug) $123.33
- Vascepa (Drug) $118.68
- LINZESS (Drug) $111.52
- Rybelsus (Drug) $107.25
- CREON (Drug) $106.78
- TRELEGY ELLIPTA (Drug) $106.64
- MYRBETRIQ (Drug) $100.62
- NASCOBAL (Drug) $100.02
- Yupelri (Drug) $80.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lake City
Miguel Tepedino, Md, MD
Family Medicine — Payments: $71,706
Dr. Richard Wright, M.d, M.D
Family Medicine — Payments: $17,641
Ernest De Leon, Md, MD
Family Medicine — Payments: $17,392
Dr. David Moon, M.d, M.D
Family Medicine — Payments: $13,012
Dr. Daniel Decamps, M.d, M.D
Family Medicine — Payments: $11,529
Jean-Felert Cadet, M.d Mph, M.D MPH
Family Medicine — Payments: $5,750